Topical Application of Vitamin D3 gel to Implant Surfaces Prior to Placement During Lateral Maxillary Sinus Augmentation: A Clinical Comparative Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202607687611415

Enrollment

Registered

2026-07-24

Start date

2024-02-18

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

Topical vitamin D3 gel applied to implant surfaces

MPM mixed with Xenograft

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • 3- 5mm residual bone height. • Missing one or more maxillary posterior teeth. • Adequate inter-arch space. • Co-operative patients.

Exclusion criteria

Exclusion criteria: • Uncontrolled systemic conditions affect bone healing or surgery. • Parafunction habits such as bruxism and clenching. • Patients with any pathological conditions related to site of surgery. • Heavy smokers. • Patients with chronic or acute infection in the maxillary sinus.

Design outcomes

Primary

Measure	Time frame
Implant stability measured by damping capacity assessment (DCA). ;Bone density assessed using cone-beam computed tomography .;Vertical bone gains following maxillary sinus augmentation.	—

Secondary

Measure	Time frame
Evaluate the clinical safety of topical Vitamin D3 gel by recording any treatment-related adverse events or postoperative complications.	—

Countries

Egypt

Contacts

Public ContactEslam Abdelaziz Sadek Aboelhassan

BDS M.Sc. OMFS General Administration of Medical Affairs Sohag University Sohag Egypt

eslam_abdelaziz_post@med.sohag.edu.eg0201097937788

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026